- 中国科技论文统计源期刊
- 中国科技核心期刊
- 中国高校优秀期刊
- 安徽省优秀科技期刊
| Citation: |
WU Yi, BAN Xiangyang, LI Binbin, YU Zhaowen. Changes of HDL-C/LDL-C, ApoA1/ApoB and Lp(a) and their relationship with the degree/number of coronary artery lesions in patients with coronary heart disease[J]. Journal of Bengbu Medical University, 2024, 49(8): 1034-1038. DOI: 10.13898/j.cnki.issn.1000-2200.2024.08.011
|
To investigate the changes of high-density lipoprotein cholesterol/low-density lipoprotein cholesterol(HDL-C/LDL-C), apolipoprotein A1/apolipoprotein B(ApoA1/ApoB) and lipoprotein a [Lp(a)] in patients with coronary heart disease(CHD), and their relationship with the degree/number of coronary artery lesions.
Ninety patients with CHD and 100 healthy subjects were divided into the CHD group and control group, respectively.The levels of HDL-C/LDL-C, ApoA1/ApoB and Lp(a) were compared between two groups, and among the patients with different degree/number of coronary artery lesions.
The levels of HDL-C/LDL-C and ApoA1/ApoB in the CHD group were lower than those in control group(P < 0.01 and P < 0.05), and the Lp(a) levels were higher than those in control group(P < 0.05).Among the 90 patients with CHD, 26 patients had single vessel lesions, 30 patients had double vessel lesions, and 34 patients had multi-vessel lesions.With the increase of the number of lesions, the levels of HDL-C/LDL-C and ApoA1/ApoB showed a decreasing trend(P < 0.01), and the level of Lp(a) showed an increasing trend(P < 0.01).The results of Pearson correlation analysis showed that the number of lesions was negatively correlated with levels of HDL-C/LDL-C and ApoA1/ApoB(r=-0.474, -0.501, P < 0.01), and positively correlated with Lp(a) level(r=0.379, P < 0.01).The results of ROC showed that the AUC and sensitivity of the combined evaluation of three indexes in CHD patients with two or more branches of lesions were higher than that of the single index diagnosis(P < 0.01), and the cut-off values of three indexes for the diagnosis of two or more branches of lesions were 0.405, 1.425 and 273.120 mg/L, respectively.
HDL-C/LDL-C, ApoA1/ApoB and Lp(a) levels are closely related to the degree/number of coronary artery lesions in patients with CHD.The combined detection of the three has a high value correlation in evaluating the degree/number of coronary artery lesions in CHD patients, and which is worthy of close monitoring in clinical practice.
| [1] |
YUE P, WU Y, ZHANG Y, et al. Contemplation-action-maintenance model of behaviour change for persons with coronary heart disease: a qualitative study[J]. J Clin Nurs, 2021, 30(9-10): 1464. doi: 10.1111/jocn.15699
|
| [2] |
任何, 汪洁, 张东伟, 等. 血清FKN、COMP、LTBP-2表达水平与冠心病严重程度的关系[J]. 中西医结合心脑血管病杂志, 2021, 19(10): 1694. doi: 10.12102/j.issn.1672-1349.2021.10.023
|
| [3] |
PODADERA-HERREROS A, ALCALA-DIAZ JF, GUTIERREZ-MARISCAL FM, et al. Long-term consumption of a Mediterranean diet or a low-fat diet on kidney function in coronary heart disease patients: the CORDIOPREV randomized controlled trial[J]. Clin Nutr, 2022, 41(2): 552. doi: 10.1016/j.clnu.2021.12.041
|
| [4] |
欧巧云, 陶丽华, 温详, 等. 非高密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值与早发男性急性ST段抬高型心肌梗死发生的相关性分析[J]. 临床内科杂志, 2022, 39(5): 318. doi: 10.3969/j.issn.1001-9057.2022.05.008
|
| [5] |
雒芳芳, 吴素萍, 许晓晗, 等. 依洛尤单抗降低老年冠心病低密度脂蛋白胆固醇水平的有效性与安全性研究[J]. 心肺血管病杂志, 2022, 41(3): 233. doi: 10.3969/j.issn.1007-5062.2022.03.004
|
| [6] |
ZHANG D, LIU X, XIAO Q, et al. Co-exposure to bisphenols, parabens, and antimicrobials and association with coronary heart disease: oxidative stress as a potential mediating factor?[J]. Environ Sci Technol, 2023, 57(1): 531. doi: 10.1021/acs.est.2c06488
|
| [7] |
詹永忠, 许贤彬, 黄泽伟. 冠心病心绞痛患者PCI围手术期CRP、Lp(a)水平检测及其与心肌损伤的相关性[J]. 中国医药导报, 2021, 18(35): 76.
|
| [8] |
中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 稳定性冠心病基层诊疗指南(2020年)[J]. 中华全科医师杂志, 2021, 20(3): 265. doi: 10.3760/cma.j.cn114798-20210120-00079
|
| [9] |
赵洁, 吕艳萍, 张皓然, 等. 血浆低密度脂蛋白与老年冠心病病情严重程度的相关性分析[J]. 河北医学, 2021, 27(11): 1836. doi: 10.3969/j.issn.1006-6233.2021.11.015
|
| [10] |
严语, 毛霄鹏. 三酰甘油-葡萄糖指数与冠心病病人冠状动脉病变严重程度的相关性分析[J]. 蚌埠医学院学报, 2023, 48(2): 195.
|
| [11] |
周茜, 白洁, 张晶. 血清同型半胱氨酸水平与冠心病严重程度关联分析[J]. 公共卫生与预防医学, 2022, 33(3): 146.
|
| [12] |
邢团结, 娄焕堃, 李鹏, 等. 血清氧化三甲胺水平与冠心病及冠状动脉狭窄程度的相关性分析[J]. 蚌埠医学院学报, 2023, 48(4): 466.
|
| [13] |
段云鹏, 刘晓豆, 刘金艳, 等. 血清非高密度脂蛋白胆固醇对老年非吸烟人群冠心病发生及冠状动脉狭窄程度的影响[J]. 中华老年多器官疾病杂志, 2022, 21(7): 511.
|
| [14] |
张劲草, 耿坡. 检测血脂及血清ApoB/ApoA1比值对冠状动脉粥样硬化临床诊断意义[J]. 标记免疫分析与临床, 2021, 28(2): 322.
|
| [15] |
宋智勇, 姜超, 罗东雷, 等. 急性冠脉综合征患者血清GDF-15、YKL-40及LDL-C/HDL-C与冠脉病变程度的关系[J]. 山东医药, 2021, 61(35): 59.
|
| [16] |
郝佳佳, 陈汉青, 丘惠嫦. 老年冠心病患者血清Lp-a、Hcy、和肽素水平变化及临床意义[ J]. 川北医学院学报, 2022, 37(10): 1253.
|
| [17] |
王宇鹏, 王宏波, 石婷, 等. 血清HCY及LP(a)的水平与冠心病的严重程度的相关性研究[J]. 湖南师范大学学报(医学版), 2021, 18(2): 1.
|
| [18] |
杨艳艳, 赵国安. 豫北地区血清脂蛋白(a)水平与冠心病的关系[J]. 心血管康复医学杂志, 2022, 31(4): 399.
|
| 1. |
包雪梅，张剑. 恩替卡韦治疗慢性乙型肝炎病毒感染患者临床疗效分析. International Infections Diseases(Electronic Edition). 2020(01): 106 .
| |
| 2. |
杨轲勇. 恩替卡韦对慢性乙型肝炎病毒感染患者HBeAg、HBV-DNA、ALT水平的影响. 临床医学工程. 2020(05): 639-640 .
| |
| 3. |
夏培华，刘丽凤，于姜标. 苦参素联合抗病毒治疗慢性乙型肝炎肝硬化的效果观察. 中国药物与临床. 2020(05): 762-764 .
| |
| 4. |
崔璐，蔡秋娥，王淼，王素华. 妊娠期乙肝患者服用替诺福韦后阻断宫内乙肝病毒传播疗效及安全性. 中国计划生育学杂志. 2020(10): 1658-1660 .
| |
| 5. |
黄修伙，罗贤鑫，陈兴. 恩替卡韦联合甘草酸二铵治疗慢性乙型肝炎的临床效果. 中国当代医药. 2020(31): 53-55 .
| |
| 6. |
庄海珍，林丽华. 双环醇片联合恩替卡韦对慢性乙型肝炎患者血清乙型肝炎病毒表面抗原丙氨酸转氨酶水平的影响. 中国药物与临床. 2019(06): 963-966 .
| |
| 7. |
刘飞飞，舒福丽，邬碧波. 恩替卡韦治疗慢性乙型肝炎病毒感染对患者HBV-DNA水平的影响及安全性观察. 临床合理用药杂志. 2019(19): 53-54 .
| |
| 8. |
俞建家. 恩替卡韦治疗慢性乙型肝炎病毒感染患者临床疗效研究. 实用心脑肺血管病杂志. 2019(S2): 93-94 .
| |
| 9. |
陈晨楠. 恩替卡韦治疗HBeAg阴性代偿期慢性乙型肝炎肝硬化的临床效果观察. 现代医学与健康研究电子杂志. 2018(14): 38 .
| |
| 10. |
梁洁玲，唐岚. 恩替卡韦对乙型肝炎病毒感染患者的临床疗效及其对肝功能的改善和HBeAg转阴的影响. 抗感染药学. 2018(09): 1587-1589 .
| |
| 11. |
曹素珍. 恩替卡韦抗乙型肝炎病毒应答不佳患者挽救方案的效果对比分析. 临床医药文献电子杂志. 2018(90): 60+62 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: